May 14 (Reuters) - Peptonic Medical AB PMED.TE :
* ENTERED INTO AN AGREEMENT TO ACQUIRE A MAJORITY OF SHARES
IN
LUNE GROUP
* PEPTONIC MEDICAL - TRANSACTION ENTAILS THAT CO ACQUIRES
60% OF
EXISTING SHARES FROM CURRENT SHAREHOLDERS AGAINST PURCHASE
PRICE OF APPROX. 1.80 MEUR
* PURCHASE PRICE SHALL BE PAID IN FORM OF NEWLY ISSUED
SHARES IN
PEPTONIC
* COMPLETION OF ACQUISITION OF EXISTING SHARES IS EXPECTED
TO
OCCUR DURING JUNE 2020
* COSTS FOR DIRECTED SHARE ISSUE TO SELLERS AND DIRECTED
SHARE
ISSUE TO VIDARSTIFTELSEN IS EXPECTED TO AMOUNT TO APPROX. 50
TSEK
* PEPTONIC HAS INCURRED COST OF APPROX. 3 MSEK IN LEGAL, DUE
DILIGENCE AND ANALYSIS COSTS PRIOR TO SIGNING
* BOARD INTENDS TO RESOLVE ON A SHARE ISSUE OF 19.2 MSEK AND
DIRECTED SHARE ISSUE OF 7.5 MSEK
Source text for Eikon: ID:nWkr7sjmNq
Further company coverage: PMED.TE
((Reuters.Briefs@thomsonreuters.com;))